https://www.cdc.gov/vaccines/hcp/imz-schedules/index.html
2025 Adult Immunization Schedule Changes:
- The 2025 schedule includes a recommendation lowering the age-based recommendations for pneumococcal vaccination from 65 to 50 years old.
- In addition to previously recommended 2024-2025 COVID-19 vaccination, the Advisory Committee on Immunization Practices (ACIP) recommends a second dose of 2024-2025 COVID-19 for adults ages 65 years and older.
- ACIP recommends a second dose of 2024-2025 COVID-19 vaccine for people ages 6 months-64 years who are moderately or severely immunocompromised.
- People ages 6 months and older who are moderately or severely immunocompromised may receive additional doses (i.e., 3 or more doses) of 2024-2025 COVID-19 vaccine under shared clinical decision-making.